ABSTRACT
Background and Objectives The SARS-CoV2 pandemic has lead to a global decrease in protection ware, especially facepiece filtering respirators (FFRs). Ultraviolet-C wavelength is a promising way of descontamination, however adequate dosimetry is needed to ensure balance between over and underexposed areas and provide reliable results. Our study demonstrates that UVGI light dosage varies significantly on different respirator angles, and propose a method to descontaminate several masks at once ensuring appropriate dosage in shaded zones.
Methods An UVGI irradiator was built with internal dimensions of 69.5 x55 × 33 cm with three 15W UV lamps. Inside, a grating of 58 × 41 × 15 cm was placed to hold the masks. Two different respirator models were used to assess irradiance, four of model Aura 9322 3M of dimensions 17 × 9 × 4cm, and two of model SAFE 231FFP3NR with dimensions 17 × 6 × 5 cm. A spectrometer STN-SilverNova was employed to verify wavelength spectrum and surface irradiance. A simulation was performed to find the irradiance pattern inside the box and the six masks placed inside. These simulations were carried out using the software DIALUX EVO 8.2.
Results The data obtained reveal that the dosage received inside the manufactured UVGI-irradiator depends not only on the distance between the luminaires plane and the base of the respirators but also on the orientation and shape of the masks. This point becomes relevant in order to assure that all the respirators inside the chamber receive the correct dosage.
Conclusion Irradiance over FFR surfaces depend on several factors such as distance, angle of incidence of the light source. Careful dosage measurement and simulation can ensure reliable dosage in the whole mask surface, balancing overexposure. Closed box systems might provide a more reliable, reproducible UVGI dosage than open settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially supported by the Consellería de Educación Program for Development of a Strategic Grouping in Materials - AeMAT Grant No. ED431E2018/08 and Xunta de Galicia ref. ED431B2017/64.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Disclosures: Authors declare that there are not conflicts of interest related to the results of this article.
Funding: This work was partially supported by the Consellería de Educación Program for Development of a Strategic Grouping in Materials – AeMAT Grant No. ED431E2018/08 and Xunta de Galicia ref. ED431B2017/64.
Abbreviations
- CDC
- Centers for Disease Control and Prevention.
- CoV2
- novel coronavirus 2.
- FFR
- facepiece filtering respirator.
- NIOSH
- National Institute for Occupational Safety and Health.
- SARS
- severe acure respiratory syndrome.
- UV-C
- ultraviolet C.
- UVGI
- ultraviolet germicidal irradiation.
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.